The use of neural networks in identifying risk factors for lymph node metastasis and recommending management of T1b esophageal cancer

American Surgeon

Volumn 78, Issue 2, 2012, Pages 195-206

  Sgourakis, George ^a,b   Gockel, Ines ^a   Lyros, Orestis ^a   Lanitis, Sophocles ^b   Dedemadi, Georgia ^b   Polotzek, Ursula ^a   Karaliotas, Constantine ^b   Lang, Hauke ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER GRADING; CANCER INVASION; COMPUTER ANALYSIS; COMPUTER MODEL; COMPUTER PREDICTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; RISK FACTOR; SYSTEMATIC REVIEW; TUMOR DIFFERENTIATION; VALIDATION PROCESS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEURAL NETWORKS (COMPUTER); RISK FACTORS;

EID: 84857071031     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (111)

1. Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001;122:1077-90.
2. Tomita N, Matsumoto T, Hayashi T, et al. Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion. Pathol Int 2008;58:282-7. (Pubitemid 351579638)
3. Kim DU, Lee JH, Min BH, et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2008;23:619-25. (Pubitemid 351501152)
4. Amano T, Matsumoto T, Hayashi T, et al. Subepithelial extension of squamous cell carcinoma in the esophagus: histopathological study using D2-40 immunostaining for 108 superficial carcinomas. Pathol Int 2007;57:759-64. (Pubitemid 350060598)
5. Natsugoe S, Matsumoto M, Okumura H, et al. Prognostic factors in patients with submucosal esophageal cancer. J Gastrointest Surg 2004;8:631-5. (Pubitemid 38881422)
6. Araki K, Ohno S, Egashira A, et al. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002;94:570-5. (Pubitemid 34081389)
7. Nakajima Y, Nagai K, Miyake S, et al. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res 2002; 93:305-12. (Pubitemid 34464367)
8. Shiozaki H, Doki Y, Yamana H, Isono K. A multiinstitutional study of immunohistochemical investigation for the roles of cyclin D1 and E-cadherin in superficial squamous cell carcinoma of the esophagus. J Surg Oncol 2002;79:166-73.
9. Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001;25: 424-31. (Pubitemid 32455192)
10. Noguchi H, Naomoto Y, Kondo H, et al. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma. Surg Laparosc Endosc Percutan Tech 2000;10:343-50. (Pubitemid 32064725)
11. Matsubara T, Ueda M, Abe T, et al. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br J Surg 1999;86:669-73. (Pubitemid 29248363)
12. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998;123:432-9. (Pubitemid 28201225)
13. Chino O, Makuuchi H, Shimada H, et al. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen. J Surg Oncol 1998; 67:18-24. (Pubitemid 28074126)
14. Makuuchi H, Shimada H, Mizutani K, et al. Clinical pathological analysis of surgically resected superficial esophageal carcinoma to determine criteria for deciding on treatment strategy. Diagn Ther Endosc 1997;3:211-20. (Pubitemid 27196707)
15. Shima I, Sasaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992;70:2747-53.
16. Manner H, May A, Pech O, et al. Early Barrett's carcinoma with 'low-risk' submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103:2589-97.
17. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005;446:497-504. (Pubitemid 40884282)
18. Buskens CJ, Westerterp M, Lagarde SM, et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004;60:703-10. (Pubitemid 39550926)
19. Shimada H, Nabeya Y, Matsubara H, et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 2006; 191:250-4. (Pubitemid 43151276)
20. Bollschweiler E, Baldus SE, Schroder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006;38:149-56. (Pubitemid 43286392)
21. Ancona E, Rampado S, Cassaro M, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008;15:3278-88.
22. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer. Comparison between adeno-and squamous cell carcinoma. Cancer 1995;76:178-86.
23. Rice TW, Zuccaro G Jr, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65:787-92. (Pubitemid 28162480)
24. Schroder W, Wirths K, Gutschow C, et al. Transthoracic esophagectomy after endoscopic mucosal resection in patients with early esophageal carcinoma. J Gastrointest Surg 2009;13:223-9.
25. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566-73; discussion 573-5.
26. Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Ann Surg Oncol 2008;15:104-16.
27. Higuchi K, Tanabe S, Koizumi W, et al. Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma. Endoscopy 2007;39:36-40. (Pubitemid 46403125)
28. Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006;19:475-80. (Pubitemid 43277003)
29. Matsumoto M, Natsugoe S, Okumura H, et al. Over-expression of vascular endothelial growth factor-C correlates with lymph node micrometastasis in submucosal esophageal cancer. J Gastrointest Surg 2006;10:1016-22. (Pubitemid 44037472)
30. Shimoyama S, Imamura K, Takeshita Y, et al. The useful combination of a higher frequency miniprobe and endoscopic submucosal dissection for the treatment of T1 esophageal cancer. Surg Endosc 2006;20:434-8. (Pubitemid 43260502)
31. Chibana Y, Fujii S, Ichikawa K, et al. Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma. J Gastroenterol Hepatol 2005;20: 1371-8. (Pubitemid 43960834)
32. Gotohda N, Nishimura M, Yoshida J, et al. The pattern of lymphatic metastases in superficial squamous cell carcinoma of the esophagus. Hepatogastroenterology 2005;52:105-7. (Pubitemid 40282642)
33. Wang GQ, Jiao GG, Chang FB, et al. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004;77: 1740-4.
34. Nozoe T, Saeki H, Ohga T, Sugimachi K. Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence. Dis Esophagus 2002;15:145-8. (Pubitemid 35264637)
35. Kuwano H, Masuda N, Kato H, Sugimachi K. The subepithelial extension of esophageal carcinoma for determining the resection margin during esophagectomy: a serial histopathologic investigation. Surgery 2002;131(suppl):S14-21. (Pubitemid 34118611)
36. Himeno S, Yasuda S, Shimada H, et al. Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol 2002;32:340-6. (Pubitemid 43102786)
37. Watanabe M, Kuwano H, Araki K, et al. Prognostic factors in patients with submucosal carcinoma of the oesophagus. Br J Cancer 2000;83:609-13. (Pubitemid 30636301)
38. Igaki H, Kato H, Tachimori Y, Nakanishi Y. Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus. J Surg Oncol 2000;75:37-41.
39. Tabira Y, Kitamura N, Yoshioka M, et al. Significance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate. J Cardiovasc Surg (Torino) 1999;40: 737-40.
40. Nakano S, Baba M, Natsugoe S, et al. Detection of lymph node metastasis using desmoglein 1 expression in superficial esophageal cancer in relation to the endoscopic mucosal resection. Dis Esophagus 1998;11:157-61. (Pubitemid 28515544)
41. Chen YJ, Lee MD, Chen PH. Diagnosis and treatment of superficial oesophageal carcinoma. J Gastroenterol Hepatol 1997; 12:778-84.
42. Bonavina L, Ruol A, Ancona E, Peracchia A. Prognosis of early squamous cell carcinoma of the esophagus after surgical therapy. Dis Esophagus 1997;10:162-4. (Pubitemid 27380075)
43. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72; discussion 372-3.
44. Hui AM, Itabashi M, Kato H, et al. Flow cytometric DNA analysis of submucosal carcinoma of the esophagus. Jpn J Clin Oncol 1994;24:26-31.
45. Nishimaki T, Tanaka O, Suzuki T, et al. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment.World J Surg 1993;17:766-71; discussion 771-2.
46. Sugimachi K, Ohno S, Matsuda H, et al. Clinicopathologic study of early stage esophageal carcinoma. Br J Surg 1989;76: 759-63. (Pubitemid 19188799)
47. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992;69:1088-93.
48. Haruma K, Tokutomi T, Tsuda T, et al. Superficial esophageal carcinoma: a report of 27 cases in Japan. Am J Gastroenterol 1991;86:1723-8.
49. Mannell A, Becker PJ. Evaluation of the results of oesophagectomy for oesophageal cancer. Br J Surg 1991;78: 36-40.
50. Ohno S, Mori M, Tsutsui S, et al. Growth patterns and prognosis of submucosal carcinoma of the esophagus. A pathologic study. Cancer 1991;68:335-40.
51. Yoshinaka H, Shimazu H, Fukumoto T, Baba M. Superficial esophageal carcinoma: a clinicopathological review of 59 cases. Am J Gastroenterol 1991;86:1413-8.
52. Kato H, Tachimori Y, Mizobuchi S, et al. Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus. Cancer 1993;72:2879-82. (Pubitemid 23335028)
53. Bogomoletz WV, Molas G, Gayet B, Potet F. Superficial squamous cell carcinoma of the esophagus. A report of 76 cases and review of the literature. Am J Surg Pathol 1989;13:535-46. (Pubitemid 19185787)
54. Schmidt LW, Dean PJ, Wilson RT. Superficially invasive squamous cell carcinoma of the esophagus. A study of seven cases in Memphis, Tennessee. Gastroenterology 1986;91:1456-61. (Pubitemid 17176861)
55. Soga J, Tanaka O, Sasaki K, et al. Superficial spreading carcinoma of the esophagus. Cancer 1982;50:1641-5. (Pubitemid 12034564)
56. Saha AK, Sutton CD, Sue-Ling H, et al. Comparison of oncological outcomes after laparoscopic transhiatal and open esophagectomy for T1 esophageal adenocarcinoma. Surg Endosc 2009;23:119-24.
57. Cen P, Hofstetter WL, Correa AM, et al. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 2008;112:1020-7. (Pubitemid 351304585)
58. Shami VM, Villaverde A, Stearns L, et al. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy. Endoscopy 2006;38:157-61. (Pubitemid 43286393)
59. Larghi A, Lightdale CJ, Memeo L, et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 2005;62:16-23. (Pubitemid 40922435)
60. Conio M, Repici A, Cestari R, et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 2005;11:6650-5. (Pubitemid 43072705)
61. Liu L, Hofstetter WL, Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 2005; 29:1079-85. (Pubitemid 41045554)
62. Peters FP, Kara MA, Rosmolen WD, et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005;61:506-14. (Pubitemid 40462188)
63. Maish MS, DeMeester SR. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004;78:1777-82. (Pubitemid 39423554)
64. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520-30; discussion 530-1.
65. van Sandick JW, van Lanschot JJ, ten Kate FJ, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000;88:2429-37.
66. Ruol A, Parenti A, Zaninotto G, et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000; 88:2520-8. (Pubitemid 30331958)
67. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23; discussion 23-5.
68. Soehendra N, Binmoeller KF, Bohnacker S, et al. Endoscopic snare mucosectomy in the esophagus without any additional equipment: a simple technique for resection of flat early cancer. Endoscopy 1997;29:380-3. (Pubitemid 27370857)
69. Sabik JF, Rice TW, Goldblum JR, et al. Superficial esophageal carcinoma. Ann Thorac Surg 1995;60:896-901; discussion 902.
70. Altorki NK, Lee PC, Liss Y, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg 2008;247:434-9.
71. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004;240:962-72; discussion 972-4.
72. Rosch T, Sarbia M, Schumacher B, et al. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy 2004;36:788-801. (Pubitemid 39207152)
73. Takeo Y, Yoshida T, Shigemitu T, et al. Endoscopic mucosal resection for early esophageal cancer and esophageal dysplasia. Hepatogastroenterology 2001;48:453-7. (Pubitemid 32391589)
74. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-94. (Pubitemid 27454450)
75. Sako A, Kitayama J, Kaisaki S, Nagawa H. Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma. Cancer Lett 2004;208:43-9. (Pubitemid 38501782)
76. Liu J, Wang Q, Li B, et al. Superficial carcinomas of the esophagus and gastric cardia. A clinicopathological analysis of 141 cases. Chin Med J (Engl) 1995;108:754-9.
77. Benasco C, Combalia N, Pou JM, Miquel JM. Superficial esophageal carcinoma: a report of 12 cases. Gastrointest Endosc 1985;31:64-7. (Pubitemid 15077692)
78. Little SG, Rice TW, Bybel B, et al. Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg 2007; 31:791-6.
79. Takubo K, Takai A, Takayama S, et al. Intraductal spread of esophageal squamous cell carcinoma. Cancer 1987;59:1751-7. (Pubitemid 17075422)
80. De Baecque C, Potet F, Molas G, et al. Superficial adenocarcinoma of the oesophagus arising in Barrett's mucosa with dysplasia: a clinico-pathological study of 12 patients. Histopathology 1990;16:213-20. (Pubitemid 20113518)
81. Ikeda Y, Ozawa S, Ando N, et al. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg 1996;62:835-8. (Pubitemid 26301785)
82. Ikeguchi M, Saito H, Katano K, et al. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. J Am Coll Surg 1997;185:398-403. (Pubitemid 27419198)
83. Tsutsui S, Kuwano H, Yasuda M, et al. Extensive spreading carcinoma of the esophagus with invasion restricted to the submucosa. Am J Gastroenterol 1995;90:1858-63.
84. Wang VS, Hornick JL, Sepulveda JA, et al. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Gastrointest Endosc 2009;69: 777-83.
85. Yoshikane H, Tsukamoto Y, Niwa Y, et al. Superficial esophageal carcinoma: evaluation by endoscopic ultrasonography. Am J Gastroenterol 1994;89:702-7. (Pubitemid 24132050)
86. Scheil-Bertram S, Lorenz D, Ell C, et al. Expression of alphamethylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus. Mod Pathol 2008;21: 961-7.
87. Kimura H, Konishi K, Maeda K, et al. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus. Hepatogastroenterology 1999;46:285-9. (Pubitemid 29154763)
88. Tauchi K, Kakudo K, Machimura T, et al. Superficial esophageal carcinoma. With special reference to basaloid features. Pathol Res Pract 1990;186:450-4. (Pubitemid 20301697)
89. Nabeya K, Hanaoka T, Li S, Nyumura T. What is the ideal treatment for early esophageal cancer? Endoscopy 1993;25:670-1. (Pubitemid 24002754)
90. Endo M, Yoshino K, Takeshita K, Kawano T. Analysis of 1.125 cases of early esophageal carcinoma in Japan. Dis Esophagus 1991;2:71-6.
91. Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis Esophagus 1997;10:155-8. (Pubitemid 27380073)
92. Ide H, Nakamura T, Hayashi K, et al. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 1994;18: 321-30. (Pubitemid 24215028)
93. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-20.
94. Nagawa H, Kaizaki S, Seto Y, et al. The relationship of macroscopic shape of superficial esophageal carcinoma to depth of invasion and regional lymph node metastasis. Cancer 1995;75: 1061-4.
95. Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol 1995;19:183-91.
96. Toh Y, Baba K, Ikebe M, et al. Endoscopic ultrasonography in the diagnosis of an early esophageal carcinoma. Hepatogastroenterology 1993;40:212-6. (Pubitemid 23212167)
97. Kitamura K, Ikebe M, Morita M, et al. The evaluation of submucosal carcinoma of the esophagus as a more advanced carcinoma. Hepatogastroenterology 1993;40:236-9. (Pubitemid 23212172)
98. Gockel I, Domeyer M, Sgourakis GG, et al. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J Surg Oncol 2009;100:191-8.
99. Inoue A, Moriya H, Katada N, et al. Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int 2008;58:611-9.
100. May A, Gunter E, Roth F, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004;53:634-40. (Pubitemid 38561439)
101. Pech O, May A, Gunter E, et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Am J Gastroenterol 2006;101: 2223-9. (Pubitemid 44477547)
102. Prasad GA, Wang KK, Lutzke LS, et al. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus. Clin Gastroenterol Hepatol 2006;4:173-8. (Pubitemid 43199687)
103. Seewald S, Akaraviputh T, Seitz U, et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003;57:854-9. (Pubitemid 47241100)
104. Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003;227:764-70. (Pubitemid 36583034)
105. Sepesi B, Watson TJ, Zhou D, et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 2010;210:418-27.
106. Guidelines for Clinical and Pathologic Studies. Carcinoma of the Esophagus. Japanese Society for Esophageal Diseases, 9th ed. Tokyo: Kanehara & Co L; 2001.
107. Albrecht RF, Reeves CR, Steele NC, (eds.). Artificial Neural Nets and Genetic Algorithms. Vienna: Springer-Verlag; 1993.
108. Kuwano H, Kitamura K, Baba K, et al. Determination of the resection line in early esophageal cancer using intraoperative endoscopic examination with Lugol staining. J Surg Oncol 1992; 50:149-52.
109. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus. Br J Surg 1997;84: 1470-3. (Pubitemid 27443460)
110. Wright A, Ricciardi TN, Zwick M. Application of information-theoretic data mining techniques in a national ambulatory practice outcomes research network. AMIA Annu Symp Proc 2005:829-33.
111. March JH. Levels of Evidence. Oxford Centre for Evidencebased Medicine: Available at: www.cebm.net/index.aspx?o41025. Last accessed Nov. 21, 2011.